| 翻訳と辞書 |
| Pittsburgh Cancer Institute ： ウィキペディア英語版 |
University of Pittsburgh Cancer Institute
The University of Pittsburgh Cancer Institute (UPCI) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center located in the Hillman Cancer Center in the Shadyside neighborhood of Pittsburgh, Pennsylvania, United States. The only NCI-designated cancer center in Western Pennsylvania, UPCI is composed of collaborative academic and research efforts between the University of Pittsburgh, the University of Pittsburgh Medical Center (UPMC), and Carnegie Mellon University.〔(【引用サイトリンク】 title=University of Pittsburgh Cancer Institute: About UPCI )〕 UPCI works in tandem with UPMC Cancer Centers to provide clinical cancer care to some 74,000 patients treated at its facilities at both the flagship Hillman Cancer Center location and at dozens of UPMC-affiliated sites throughout the Pittsburgh region as well as at a growing list of overseas locations. Founded in 1984, UPCI became the youngest cancer center in history to achieve NCI-designation, and as of 2007 received nearly $200 million in funding from the National Cancer Institute ranking it in the top ten of all cancer research institutes.〔
==Cancer Institute==
The UPCI was founded in 1984 under the direction of Ronald B. Herberman, MD.〔(【引用サイトリンク】 title=University of Pittsburgh Cancer Institute: Welcome )〕 UPCI remains the only NCI-designated Comprehensive Cancer Center in Western Pennsylvania, and today is composed of 625 research faculty members specializing in disciplines ranging from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end of life care. While most UPCI faculty maintain academic appointments at the University of Pittsburgh and physician-scientists maintain their clinical appointments through UPMC hospitals, some UPCI members are affiliated solely with UPMC or neighboring Carnegie Mellon University. Four target research areas of molecular and medical oncology at the institute include 1) the biological basis of cancer development and progression; 2) identification of new biomarkers for improved cancer detection and diagnosis; 3) the development of novel therapeutics for successful and comprehensive cancer treatment; and 4) establish and implement effect cancer prevention measures.〔 Over the last five years, UPCI's 350 faculty members have published more than 4,500 publications in peer-reviewed journals.
UPCI is ranked 12th in funding from the National Cancer Institute. It has increased its federal research funding to a total of nearly $174 million in 2011; up from totals of $154 million in 2007, $149 million in 2004, and $120 million in 2001. These totals include three competitive Specialized Program of Research Excellence (SPORE) grants focusing on head and neck, lung, and skin cancers. UPCI works in tandem with UPMC Cancer Centers Network to translate the latest research advances to clinical application for patients. UPCI also offers a variety of education, training programs and fellowships, in conjunction with related schools within the University of Pittsburgh, for both new cancer researchers to experienced investigators.〔(【引用サイトリンク】 title=University of Pittsburgh Cancer Institute: Education and Training )〕 The current director of the UPCI and UPMC Cancer Centers is Nancy E. Davidson, MD.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「University of Pittsburgh Cancer Institute」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|